Results 11 to 20 of about 148,446 (303)

Venous thromboembolism [PDF]

open access: yesBritish Journal of Surgery, 2013
Extended ...
G, Stansby, D, Berridge
openaire   +3 more sources

Venous Thromboembolic Disease [PDF]

open access: yesSurgical Clinics of North America, 2013
Venous thromboembolic disease is extremely common. Conventional treatment with anticoagulation alone aims to impede the progression of thrombus, and prevent recurrence and the development of pulmonary embolism. This is appropriate for most patients.
Pasithorn A, Suwanabol, John R, Hoch
openaire   +4 more sources

The use of anticoagulants in chronic kidney disease: Common point of view of cardiologists and nephrologists

open access: yesCardiology Journal, 2020
In patients diagnosed with chronic kidney disease (CKD), atrial fibrillation (AF) is associated with an increased risk of thromboembolism and stroke. Moreover, patients with CKD — especially those in end-stage renal disease — also present an increased ...
Justyna Domienik-Karłowicz   +4 more
doaj   +1 more source

Chronic hypersensitivity pneumonitis is associated with an increased risk of venous thromboembolism: a retrospective cohort study

open access: yesBMC Pulmonary Medicine, 2021
Background Idiopathic pulmonary fibrosis (IPF) and chronic hypersensitivity pneumonitis share commonalities in pathogenesis shifting haemostasis balance towards the procoagulant and antifibrinolytic activity.
Małgorzata Sobiecka   +10 more
doaj   +1 more source

Venous thromboembolism in cancer surgery: A report from the nationwide readmissions database

open access: yesSurgery Open Science, 2022
Background: The present study characterized the incidence of venous thromboembolism in a contemporary cohort of surgical oncology patients and its association with index hospitalization and postdischarge outcomes.
Chelsea S. Pan, BA   +5 more
doaj   +1 more source

Risk marker associations with venous thrombotic events: a cross-sectional analysis. [PDF]

open access: yes, 2014
ObjectiveTo examine the interrelations among, and risk marker associations for, superficial and deep venous events-superficial venous thrombosis (SVT), deep venous thrombosis (DVT) and pulmonary embolism (PE).DesignCross-sectional analysis.SettingSan ...
Chan, Virginia T   +4 more
core   +1 more source

Molecular Analysis of Prothrombotic Gene Variants in Venous Thrombosis: A Potential Role for Sex and Thrombotic Localization [PDF]

open access: yes, 2020
Background: Requests to test for thrombophilia in the clinical context are often not evidence-based. Aim: To define the role of a series of prothrombotic gene variants in a large population of patients with different venous thromboembolic diseases ...
AMATO, FELICE   +9 more
core   +1 more source

Extended thromboprophylaxis with betrixaban in acutely ill medical patients [PDF]

open access: yes, 2016
BACKGROUND: Patients with acute medical illnesses are at prolonged risk for venous thrombosis. However, the appropriate duration of thromboprophylaxis remains unknown.
. Lodigiani, M   +18 more
core   +1 more source

Genome-wide cross-trait analysis and Mendelian randomization reveal a shared genetic etiology and causality between COVID-19 and venous thromboembolism

open access: yesCommunications Biology, 2023
Venous thromboembolism occurs in up to one-third of patients with COVID-19. Venous thromboembolism and COVID-19 may share a common genetic architecture, which has not been clarified.
Xin Huang   +6 more
doaj   +1 more source

Cancer patients’ experiences of living with venous thromboembolism: A systematic review and qualitative thematic synthesis [PDF]

open access: yes, 2018
Background: Cancer-Associated thrombosis is common. Recommended treatment is daily injected low-molecular-weight heparin for 6months. Most studies focus on prophylaxis and treatment; few have explored patients’ experience.
Benelhaj, Naima B.   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy